Burcon Begins Commercial Production of Pea Protein at Illinois Facility, Targets 2026 Profitability
Burcon NutraScience has commenced commercial production of its Peazazz C pea protein at its newly acquired manufacturing facility in Galesburg, Illinois. This marks the first time the company has had direct operational control over a commercial-scale production site. Quick ramp-up and forecasts The facility became operational less than three months after commissioning and is now ramping up output through the second half of 2025. The company projects between $1 million and $3 million in revenue for the calendar year 2025, and over $10 million in 2026. Positive cash flow is anticipated by the end of 2026. “The successful startup of our Galesburg facility marks a key operational milestone in Burcon’s commercial scale-up. In less than 90 days since commissioning, our team has brought next-generation protein …